IQVIA Holdings Inc. (NYSE: IQV), a global provider of advanced analytics solutions and clinical research services to the life sciences industry, reported
Earnings Summary: IQVIA reports higher revenue and adj. profit for Q2 2024
Categories
Healthcare Technology
Intuitive Surgical likely to report strong revenue, profit growth for Q2 2024
Intuitive Surgical, Inc. (NASDAQ: ISRG) is expected to report its second-quarter earnings next week, amid expectations for strong revenue and profit growth.
MEDS Earnings: Highlights of Trxade Health’s Q1 2024 financial results
Trxade Health, Inc. (NASDAQ: MEDS), a leading health service IT company, reported financial results for the first quarter of 2024. The company
Tempus AI gears up for IPO. Here’s everything you need to know
The IPO market witnessed stronger activity so far this year compared to the corresponding period last year, with a marked increase in
Earnings: Trxade Health (MEDS) reports lower revenues for fiscal 2023
Trxade Health, Inc. (NASDAQ: MEDS), a leading health service IT company, reported a decline in revenues for fiscal 2023. The company’s full-year
Medtronic (MDT) Q3 2024 revenue rises 5%; adj. earnings flat
Medical device maker Medtronic plc (NYSE: MDT) reported an increase in revenues for the third quarter of 2024 when the company's adjusted
Earnings Summary: Baxter International reports higher Q4 sales and adj. profit
Medical device maker Baxter International Inc. (NYSE: BAX) has announced financial results for the fourth quarter of 2023, reporting higher revenues and
Earnings Summary: Catalent (CTLT) slips to a loss in Q2; revenue down 10%
Catalent, Inc. (NYSE: CTLT), a provider of delivery technologies and development solutions to the pharmaceutical industry, on Friday reported a net loss
Earnings Summary: Everything you need to know about IDEXX’s Q4 2023 report
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a provider of pet healthcare innovation, on Monday reported higher revenues and net income for the fourth
Thermo Fisher Scientific (TMO) Q4 adj. earnings rise; revenue down 5%
Thermo Fisher Scientific Inc. (NYSE: TMO) on Wednesday announced fourth-quarter 2023 financial results, reporting higher adjusted earnings, despite a decrease in revenues.
Earnings Summary: Highlights of DexCom’s Q4 2023 financial results
Healthcare company DexCom, Inc. (NASDAQ: DXCM) announced preliminary results for the fourth quarter of 2023, reporting an estimated double-digit increase in revenues.
ANGO Earnings: A snapshot of AngioDynamics’ Q2 2024 results
AngioDynamics Inc. (NASDAQ: ANGO) on Wednesday reported a net loss, on an adjusted basis, for the second quarter of 2024 when its
Earnings Summary: Highlights of CooperCompanies’ (COO) Q4 2023 financial results
Medical device maker CooperCompanies (NYSE: COO) announced financial results for the fourth quarter of 2023, reporting an increase in revenues and adjusted
Earnings Summary: Henry Schein (HSIC) Q3 2023 financial results
Henry Schein, Inc. (Nasdaq: HSIC), a provider of healthcare solutions to office-based dental and medical practitioners, reported financial results for the third quarter
Earnings Summary: Becton, Dickinson, and Company reports Q4 2023 results
Medical technology company Becton, Dickinson, and Company (NYSE: BDX) announced results for the final three months of fiscal 2023. Fourth-quarter revenue increased
Earnings Summary: A snapshot of Zimmer Biomet Holdings’ Q3 2023 results
Medical technology company Zimmer Biomet Holdings, Inc. (NYSE: ZBH) on Tuesday reported an increase in third-quarter sales and adjusted profit. Third-quarter net
Earnings Summary: A snapshot of IQVIA Holdings’ Q3 2023 results
IQVIA Holdings Inc. (NYSE: IQV), a global provider of advanced analytics solutions and clinical research services to the life sciences industry, reported
Agilent Technologies (A) Q2 2023 earnings, revenue increase
Agilent Technologies (NYSE: A) has announced second-quarter 2023 financial results, reporting an increase in adjusted profit and revenues. The Santa Clara, California-based
Trxade Health Inc. (NASDAQ: MEDS) Q4 2022 Research Summary
Trxade Health Inc. (NASDAQ: MEDS), an integrated drug procurement and delivery platform, is on a mission to empower the independent pharmacy market
Trxade explores alternative ways to find partners for B2C assets: CEO Suren Ajjarapu
Trxade Health Inc. (NASDAQ: MEDS) is a health service IT company that is on a mission to enable independent pharmacies to operate
Earnings: Trxade Health (MEDS) reports 6% drop in Q3 revenue; loss narrows
Trxade Health Inc (NASDAQ: MEDS), a leading health service IT company, reported a modest decline in its third-quarter revenues. Meanwhile, the company's